TherapeuticsMD (NYSEMKT:TXMD), A rise of 755,477 shares or 2.2% was seen in the short interest of TherapeuticsMD, Inc.. Even as the interest increased from 34,330,927 shares on May 31,2016 to 35,086,404 shares on June 15,2016, the days to cover came in at 34. The updated interest stood at 22.8% of the stocks floats. The stock has seen an average daily volume of 1,030,152 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th after market close.
TherapeuticsMD (NYSEMKT:TXMD): The stock opened at $8.21 on Friday but the bulls could not build on the opening and the stock topped out at $8.68 for the day. The stock traded down to $8.21 during the day, due to lack of any buying support eventually closed down at $8.32 with a loss of -5.99% for the day. The stock had closed at $8.85 on the previous day. The total traded volume was 2,612,773 shares.
The company shares have rallied 11.53% from its 1 Year high price. On Dec 29, 2015, the shares registered one year high at $11.26 and the one year low was seen on Oct 22, 2015. The 50-Day Moving Average price is $8.43 and the 200 Day Moving Average price is recorded at $7.79.
TherapeuticsMD (NYSEMKT:TXMD) has tumbled 0.83% during the past week and has dropped 5.45% in the last 4 week period. The company has outperformed the S&P 500 by 0.81% in the past week but underperformed the index by 2.59% in the last 4 weeks.
TherapeuticsMD, Inc. is a womens health care product company. The Company is engaged in creating and commercializing products for women. The Company is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. It manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. It markets its prescription and OTC prenatal vitamins and other products under its vitaMedMD brand name and duplicate formulations of its prescription prenatal vitamin products, also referred to as generic formulations, under its BocaGreenMD brand name. The Companys products include prenatal vitamins, vitaMedMD Plus Rx, vitaMedMD One Rx, vitaMedMD RediChew Rx and BocaGreenMD Prena1 line of prescription prenatal vitamins, which included three prescription prenatal vitamins that were generic formulations of its vitaMedMD-branded prescription prenatal vitamins.